J2KBIO Co., Ltd. (KOSDAQ:420570)

J2KBIO Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 18, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	49,236	51,996	-	-	-	-
Enterprise Value	39,019	41,858	-	-	-	-
Last Close Price	8420.00	8842.65	-	-	-	-
PS Ratio	1.58	1.57	-	-	-	-
PB Ratio	1.49	1.66	-	-	-	-
P/TBV Ratio	1.51	1.68	-	-	-	-
P/FCF Ratio	72.07	2224.56	-	-	-	-
P/OCF Ratio	26.93	7.51	-	-	-	-
EV/Sales Ratio	1.25	1.26	-	-	-	-
EV/EBITDA Ratio	10.35	8.82	-	-	-	-
EV/EBIT Ratio	17.05	11.54	-	-	-	-
EV/FCF Ratio	57.11	1790.83	-	-	-	-
Debt / Equity Ratio	0.03	0.07	0.07	0.42	0.59	0.70
Debt / EBITDA Ratio	0.30	0.44	0.20	1.59	2.20	3.45
Debt / FCF Ratio	1.64	89.34	0.65	3.46	4.36	-
Net Debt / Equity Ratio	-0.31	-0.35	-0.18	-0.05	0.04	0.34
Net Debt / EBITDA Ratio	-2.71	-2.31	-0.51	-0.18	0.14	1.67
Net Debt / FCF Ratio	-14.95	-469.14	-1.65	-0.38	0.27	-2.41
Asset Turnover	0.85	1.14	1.44	0.95	0.97	-
Inventory Turnover	6.24	7.27	6.47	5.03	7.59	-
Quick Ratio	4.96	6.64	2.90	2.52	2.37	2.51
Current Ratio	6.19	7.88	3.78	3.26	2.87	3.02
Return on Equity (ROE)	7.05%	-6.80%	33.43%	20.83%	20.06%	-
Return on Assets (ROA)	3.91%	7.82%	17.69%	8.60%	7.97%	-
Return on Invested Capital (ROIC)	9.40%	20.70%	38.56%	22.38%	19.77%	11.61%
Return on Capital Employed (ROCE)	6.70%	10.80%	30.60%	16.20%	14.30%	10.10%
Earnings Yield	4.56%	-3.18%	-	-	-	-
FCF Yield	1.39%	0.04%	-	-	-	-
Dividend Yield	2.93%	2.26%	-	-	-	-
Payout Ratio	51.02%	-	4.96%	-	-	-
Buyback Yield / Dilution	-8.67%	-9.44%	-3.97%	-8051.19%	-	-
Total Shareholder Return	-5.74%	-7.18%	-3.97%	-8051.19%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.